placebo with matching dosage + ECNOGLUTIDE for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Nov 2025: Trial started, NCT07243171
  2. 21 Nov 2025: Trial registered, NCT07243171

The trials

NCT07243171: A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

State
Under way
Phase
Phase 1 and Phase 2
People
126 planned
Started
18 Nov 2025
Primary completion
5 Jan 2027
Arms
oral ecnoglutide C1, oral ecnoglutide C2, oral ecnoglutide C3, oral ecnoglutide C4, oral ecnoglutide C5, oral ecnoglutide C6
Results
None posted
  1. 18 Nov 2025: Trial started
  2. 21 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.